Prevalencia y factores predictivos del dolor por cáncer
DOI:
https://doi.org/10.51481/amc.v44i4.430Palabras clave:
dolor canceroso , cáncer , prevalencia , epidemiologíaResumen
El dolor en los enfermos de cáncer constituye un problema de salud pública a nivel mundial, afectando frecuentemente la calidad de vida de estos pacientes. Su prevalencia e intensidad varía según el sitio de origen del tumor, el estadío de la enfermedad, la prescripción incorrecta de analgésicos y algunas variables sociodemográficas. La epidemiología del dolor por cáncer es esencial para establecer prioridades al definir políticas de atención del dolor y de cuidados paliativos. Se presenta una revisión y análisis de la literatura mundial, en torno a la prevalencia y los factores predictivos del dolor por cáncer.
Descargas
Citas
World Health Organization. Cancer Pain Relief and Palliative Care:report of a expert committee. Génova: World Health Organisation,1990.
Schug SA, Zech D, Dorr U. Cancer pain management according toWHO analgesic guidelines. J Pain Symptom Manage 1990; 5(1):27-32.
Franks PJ, Salisbury C, Bosanquet N, Wilkinson EK, Lorentzon M,Kite S et al. The level of need for palliative care: a systematic reviewof the literature. Palliat Med 2000; 14(2):93-104
Foley KM. Pain syndromes in patients with cancer. En: Bonica JJ et al,eds. Advances in pain research and therapy: International symposiumon pain in advanced cancer. New York: Raven Press, 1979:59-75.
Spiegel D, Bloom JR. Pain in metastatic breast cancer. Cancer 1983;52:341-345.
Peteet J, Tay V, Cohen G, MacIntyre J.. Pain characteristics and treat-ment in an outpatient cancer population. Cancer 1986; 57:1259-1265.
Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in fourcancers. Cancer 1987; 60:2563-2569.
Portenoy RK, Miransky J, Thaler HT, Hornung J, Bianchi C, Cibas-Kong I et al. Pain in ambulatory patients with lung or colon cancer.Cancer 1992; 70(6):1616-1624.
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, StewartJAet al. Pain and its treatment in out patients with metastatic cancer. NEngl J Med 1994; 330:592-596.
Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study ofcancer pain and its treatment in France. BMJ 1995; 310:1034-1037.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer.Cancer 1982; 50:1913-1918.
Vainio A, Auvinen A. Prevalence of symptoms among patients withadvanced cancer: aninternationalcollaborative study. SymptomPrevalence Group. J Pain Symptom Manage 1996; 12(1):3-10.
Beck SL, Falkson G. Prevalence and management of cancer pain inSouth Africa. Pain 2001; 94:75-84.
Foley KM. Management of pain of malignant origin. En: Tyler HR,Dawson PM, eds. Current Neurology, vol. 2. Boston: HoughtonMifflin, 1979:279.
Higginson IJ, Eran J. A multicenter evaluation of cancer pain control bypalliative care teams. J Pain Symptom Manage 1997; 14(1):29-35.Dolor por cáncer/ Rojas J. y Salas I.
AMC, octubre-diciembre 2002, vol 44 (4)
McCarthy EP, et al. Dying with cancer: patients’ function, symptoms,and care preferences as death approaches. J Am Geriatr Soc 2000; 48(5Suppl):S110-S121.
Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treat-ment of pain in minority patients with cancer. Ann Intern Med 1997;127:813-816.
Anderson KO, Mendoza TR, Valero V, Richman SP, Russell C, HurleyJ et al. Minority cancer patients and their providers: pain managementattitudes and practice. Cancer 2000; 88(8):1929-1938.
Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R etal. Management of pain in elderly patients with cancer. JAMA 1998;279(23):1877-1882.
Andersen G, Sjogren P. Epidemiology of cancer pain. Ugeskr Laeger1998; 160(18): 2681-2684.
Zeppetella G, O’ Doherty CA, Collins S. Prevalence and characteristicsof breakthrough pain in cancer patients admitted to a hospice. J PainSymptom Manage 2000; 20(2):87-92.
Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern ofsymptoms in patients with cancer pain: a prospective evaluation of1635 cancer patients referred to a pain clinic. J Pain Symptom Manage1994; 9(6):372-382.
Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S.Symptoms during cancer pain treatment following WHO-guidelines: alongitudinal follow up study of symptom prevalence, severity and eti-ology. Pain 2001; 93:247-257.
Dobratz MC, Burns KM, Oden RV. Pain in home hospice patients: anexploratory descriptive study. Hosp J 1989; 5(3-4):117-133.
Ger LP, Ho ST, Wang JJ, Cherng CH. The prevalence and severity ofcancer pain: a study of newly-diagnosed cancer patients in Taiwan. JPain Symptom Manage 1998; 15(5):285-293.
Wells N. Pain intensity and pain interference in hospitalized patientswith cancer. Oncol Nurs Forum 2000; 27(6):985-991.
Gordon C. The effect of cancer pain on quality of life in different eth-nic groups: a literature review. Nurse Pract Forum 1997; 8(1): 5-13.
Sterlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS.When is cancer pain mild, moderate or severe? Grading pain severityby its interference with function. Pain 1995; 61:277-284.
Ministerio de Salud. Incidencia y mortalidad por tumores malignos.San José: Ministerio de Salud, 1996.
Stjernsward J. WHO cancer pain relief programme. Cancer Surv 1988;7(1):195-208.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2008 Acta Médica Costarricense
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
